The cell and gene therapy manufacturing market is anticipated to expand at a 17.3% CAGR between 2023 and 2031. The market has emerged as a revolutionary segment of the biopharmaceutical industry, revolutionizing medical treatment through personalized therapies. The Cell and Gene Therapy Manufacturing Market is driven by technological advancements in cellular engineering, rising disease prevalence, and a regulatory environment that ...
Read More »